WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
266.7 |
mg/dl |
13.9 |
31.08 |
oral glucose tolerance test |
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12892 |
321 |
BN/CrlCrlj |
serum insulin level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood insulin amount |
male |
120 days
| 5 |
0.0 |
mg/dl |
0.0 |
0.0 |
oral glucose tolerance test |
|
glucose challenge |
0 |
min |
|
serum glucose |
|
12911 |
321 |
BN/CrlCrlj |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
120 days
| 5 |
0.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67776 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
145.1 |
mg/dl |
16.4 |
36.67 |
oral glucose tolerance test |
|
glucose challenge |
0 |
min |
|
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12907 |
321 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
313.5 |
mg/dl |
25.9 |
57.91 |
oral glucose tolerance test |
|
glucose challenge |
60 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12895 |
321 |
WBN/KobSlc |
serum insulin level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood insulin amount |
male |
120 days
| 5 |
0.0 |
mg/dl |
0.0 |
0.0 |
oral glucose tolerance test |
|
glucose challenge |
0 |
min |
|
serum glucose |
|
12900 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
178.1 |
mg/dl |
7.9 |
17.66 |
oral glucose tolerance test |
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12908 |
321 |
WBN/KobSlc |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
90 days
| 13 |
69.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67772 |
321 |
BN/CrlCrlj |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
90 days
| 5 |
0.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67773 |
321 |
WBN/KobSlc |
serum insulin level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood insulin amount |
male |
120 days
| 5 |
0.0 |
mg/dl |
0.0 |
0.0 |
oral glucose tolerance test |
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
|
12904 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
211.3 |
mg/dl |
17.9 |
40.03 |
oral glucose tolerance test |
|
glucose challenge |
60 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12909 |
321 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
140.2 |
mg/dl |
13.4 |
29.96 |
oral glucose tolerance test |
|
glucose challenge |
0 |
min |
|
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12887 |
321 |
BN/CrlCrlj |
serum insulin level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood insulin amount |
male |
120 days
| 5 |
0.0 |
mg/dl |
0.0 |
0.0 |
oral glucose tolerance test |
|
glucose challenge |
30 |
min |
glucose dose not specified |
serum glucose |
|
12912 |
321 |
WBN/KobSlc |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
150 days
| 5 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67775 |
321 |
BN/CrlCrlj |
body weight |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
body mass |
male |
120 days
| 5 |
248.0 |
g |
4.3 |
9.62 |
body weighing method |
|
|
0 |
|
|
|
|
12913 |
321 |
WBN/KobSlc |
body weight |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
body mass |
male |
120 days
| 5 |
332.7 |
g |
6.1 |
13.64 |
body weighing method |
|
|
0 |
|
|
|
|
12906 |
321 |
WBN/KobSlc |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
120 days
| 5 |
100.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67774 |
321 |
BN/CrlCrlj |
percentage of study population developing chronic pancreatitis during a period of time |
controlled protein content diet |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
pancreas integrity trait |
male |
150 days
| 6 |
0.0 |
% |
|
|
ex vivo light microscopy |
0.0 |
|
0 |
|
|
|
|
67777 |
321 |
WBN/KobSlc |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
216.9 |
mg/dl |
8.6 |
19.23 |
oral glucose tolerance test |
|
glucose challenge |
120 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12896 |
321 |
BN/CrlCrlj |
blood glucose level |
controlled protein content diet (for 120 days) then fasting (for 9 hours) then glucose solution |
Tsuji A, et al., Genomics 2001 Jun 15;74(3):365-9. |
blood glucose amount |
male |
120 days
| 5 |
154.7 |
mg/dl |
13.8 |
30.86 |
oral glucose tolerance test |
|
glucose challenge |
120 |
min |
glucose dose not specified |
serum glucose |
WBN/Kob rats were studied as a model of pancreatitis and diabetes mellitus |
12910 |
321 |